Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Cost Analysis of Interstim Therapy

This study has been completed.
Sponsor:
Information provided by:
MedtronicNeuro
ClinicalTrials.gov Identifier:
NCT00200031
First received: September 12, 2005
Last updated: July 24, 2008
Last verified: July 2008
  Purpose

A study to examine the impact that Interstim Therapy for Urinary Control has on health care utilization and costs within a health care system and the satisfaction with treatment expressed by patients using this therapy.


Condition Intervention
Urinary Retention and Symptoms of Overactive Bladder (Urge, Frequency)
Device: Interstim therapy

Study Type: Observational
Official Title: Interstim Therapy Retrospective Cost Analysis and Quality of Life

Further study details as provided by MedtronicNeuro:

Estimated Enrollment: 150
Study Start Date: July 2005
Study Completion Date: April 2006
Detailed Description:

A retrospective administrative data analysis combined with a prospective health related quality of life/satisfaction with treatment survey designed to examine the impact that Interstim Therapy for Urinary Control has had on health care utilization and costs for the Kaiser Permanente system and the satisfaction with treatment expressed by patients using this therapy.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Patients implanted with an Interstim Therapy for Urinary Control or undergoing test stimulation for potential placement of Interstim Therapy during the period of June 1, 2002 through June 30, 2004 and who are enrolled with Kaiser-Permanente of Southern California.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00200031

Locations
United States, California
Southern California Permanente Medical Group
Los Angeles, California, United States, 90027
Sponsors and Collaborators
MedtronicNeuro
Investigators
Principal Investigator: Sherif Aboseif, MD Kaiser Permanente
  More Information

Publications:
ClinicalTrials.gov Identifier: NCT00200031     History of Changes
Other Study ID Numbers: 4348
Study First Received: September 12, 2005
Last Updated: July 24, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Urinary Bladder, Overactive
Urinary Retention
Lower Urinary Tract Symptoms
Signs and Symptoms
Urinary Bladder Diseases
Urination Disorders
Urologic Diseases
Urological Manifestations

ClinicalTrials.gov processed this record on November 27, 2014